Jasreet Hundal
Jasreet Hundal
McDonnell Genome Institute at Washington University
Dirección de correo verificada de
Citado por
Citado por
DNMT3A Mutations in Acute Myeloid Leukemia
TJ Ley, L Ding, MJ Walter, MD McLellan, T Lamprecht, DE Larson, ...
New England Journal of Medicine 363 (25), 2424-2433, 2010
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ...
Nature 515 (7528), 577-581, 2014
The origin and evolution of mutations in acute myeloid leukemia
JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ...
Cell 150 (2), 264-278, 2012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
H Matsushita, MD Vesely, DC Koboldt, CG Rickert, R Uppaluri, VJ Magrini, ...
Nature 482 (7385), 400-404, 2012
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
BM Carreno, V Magrini, M Becker-Hapak, S Kaabinejadian, J Hundal, ...
Science 348 (6236), 803-808, 2015
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ...
Nature 518 (7540), 552-555, 2015
Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens
J Hundal, BM Carreno, AA Petti, GP Linette, OL Griffith, ER Mardis, ...
Genome medicine 8 (1), 1-11, 2016
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune EscapeThe Role of Tumor versus Host PD-L1 in Tumor Immune Escape
T Noguchi, JP Ward, MM Gubin, CD Arthur, SH Lee, J Hundal, MJ Selby, ...
Cancer immunology research 5 (2), 106-117, 2017
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
Genomic impact of transient low-dose decitabine treatment on primary AML cells
JM Klco, DH Spencer, TL Lamprecht, SM Sarkaria, T Wylie, V Magrini, ...
Blood, The Journal of the American Society of Hematology 121 (9), 1633-1643, 2013
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
T Okeyo-Owuor, BS White, R Chatrikhi, DR Mohan, S Kim, M Griffith, ...
Leukemia 29 (4), 909-917, 2015
Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation
H Celik, C Mallaney, A Kothari, EL Ostrander, E Eultgen, A Martens, ...
Blood, The Journal of the American Society of Hematology 125 (4), 619-628, 2015
The prognostic effects of somatic mutations in ER-positive breast cancer
OL Griffith, NC Spies, M Anurag, M Griffith, J Luo, D Tu, B Yeo, J Kunisaki, ...
Nature communications 9 (1), 1-16, 2018
pVACtools: A Computational Toolkit to Identify and Visualize Cancer NeoantigenspVACtools: Toolkit for Tumor Neoantigen Characterization
J Hundal, S Kiwala, J McMichael, CA Miller, H Xia, AT Wollam, CJ Liu, ...
Cancer immunology research 8 (3), 409-420, 2020
Genome modeling system: a knowledge management platform for genomics
M Griffith, OL Griffith, SM Smith, A Ramu, MB Callaway, AM Brummett, ...
PLoS computational biology 11 (7), e1004274, 2015
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor ImmunityBreast Cancer Neoantigens Can Induce Antitumor Immunity
X Zhang, S Kim, J Hundal, JM Herndon, S Li, AA Petti, SD Soysal, L Li, ...
Cancer immunology research 5 (7), 516-523, 2017
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples
EK Barnell, P Ronning, KM Campbell, K Krysiak, BJ Ainscough, LM Sheta, ...
Genetics in Medicine 21 (4), 972-981, 2019
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial
R Lesurf, OL Griffith, M Griffith, J Hundal, L Trani, MA Watson, R Aft, ...
Annals of Oncology 28 (5), 1070-1077, 2017
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group
L De Mattos-Arruda, M Vazquez, F Finotello, R Lepore, E Porta, J Hundal, ...
Annals of oncology 31 (8), 978-990, 2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20